Can umbilical artery pulsatility index predict the outcome of fetuses with structural heart disease?

J A Copel1, J C Hobbins, C S Kleinman

  • 1Yale Fetal Cardiovascular Center, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510-8063.

Insights

Umbilical artery Doppler pulsatility index (PI) was not a reliable indicator for fetuses with congenital heart disease (CHD). Elevated PI was observed in some cases, but it did not accurately predict disease severity or outcome.

Area of Science:

  • Perinatology
  • Fetal Medicine
  • Cardiology

Background:

  • Umbilical artery Doppler waveforms are used to assess fetal well-being.
  • Diminished end-diastolic velocities have been suggested in fetuses with congenital heart disease (CHD).

Purpose of the Study:

  • To evaluate the utility of umbilical artery Doppler pulsatility index (PI) in fetuses diagnosed with congenital heart disease (CHD).

Main Methods:

  • Assessed 11 fetuses with antenatally diagnosed CHD (19-32 weeks gestation).
  • Compared umbilical artery pulsatility index (PI) to normal gestational age percentiles.
  • Analyzed PI in relation to chromosomal status and lesion fatality.

Main Results:

  • Elevated PI (above 90th percentile) was found in 3 out of 11 fetuses with CHD.
  • Elevated PI did not reliably differentiate between fatal and non-fatal cardiac lesions.
  • Five of eight fetuses with fatal anomalies had normal PI values.

Conclusions:

  • Umbilical artery PI elevation in a subgroup of fetuses with CHD was not clinically useful for predicting outcomes.
  • Further research may be needed to identify more accurate Doppler markers for fetal CHD assessment.